
Xenon Pharmaceuticals Inc. (XENE)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
55.24 - Open
55.03 - Bid 54.14 x 100
- Ask 54.32 x 100
- Day's Range
54.02 - 56.11 - 52 Week Range
28.19 - 63.95 - Volume
678,228 - Avg. Volume
1,347,895 - Market Cap (intraday)
5.244B - Beta (5Y Monthly) 0.75
- PE Ratio (TTM)
-- - EPS (TTM)
-4.36 - Earnings Date (est.) May 11, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
79.24
Recent News: XENE
View MorePerformance Overview: XENE
Trailing total returns as of 4/27/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends: XENE
View MoreAnalyst Insights: XENE
View MoreStatistics: XENE
View MoreValuation Measures
-
Market Cap
5.33B
-
Enterprise Value
4.79B
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
583.31
-
Price/Book (mrq)
9.17
-
Enterprise Value/Revenue
639.17
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-32.58%
-
Return on Equity (ttm)
-51.76%
-
Revenue (ttm)
7.5M
-
Net Income Avi to Common (ttm)
-345.91M
-
Diluted EPS (ttm)
-4.36
Balance Sheet and Cash Flow
-
Total Cash (mrq)
548.89M
-
Total Debt/Equity (mrq)
1.37%
-
Levered Free Cash Flow (ttm)
-175.08M
Compare To: XENE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.








